Rigel Pharmaceuticals has seen its fair value estimate nudged up from US$49.60 to US$51.20, with only a small adjustment to the discount rate from 7.12% to 7.14% and revenue growth assumptions kept at ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Drs Harrington and Gibson’s annual review of cardiovascular medicine: ACS guidelines, antiplatelet management, GLP-1s, and ...
The paper addresses the AI shutdown problem, a long-standing challenge in AI safety. The shutdown problem asks how to design AI systems that will shut down when instructed, will not try to prevent ...
Our Call: A bevy of nice, gently cheesy moments may endear you to The Son of a Thousand Men, but its slow, two-hour plod to a ...
Morning Overview on MSN
Quantum system discovered that refuses to heat up
A team of physicists has created a cloud of ultracold atoms that stubbornly resists the most basic rule of everyday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback